| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Hiroyuki Tomita | Q87735607 |
| P2093 | author name string | Akira Hara | |
| Hirohito Yano | |||
| Toru Iwama | |||
| Akio Soeda | |||
| Masafumi Miyai | |||
| P2860 | cites work | An integrated genomic analysis of human glioblastoma multiforme | Q24648860 |
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis | Q28255073 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects | Q28511432 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| The evidence of glioblastoma heterogeneity | Q30300892 | ||
| Transforming fusions of FGFR and TACC genes in human glioblastoma | Q30540467 | ||
| Glial promoter selectivity following AAV-delivery to the immature brain | Q31120301 | ||
| Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts | Q33953822 | ||
| CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway | Q34018947 | ||
| Gliomagenesis: genetic alterations and mouse models | Q34186001 | ||
| Studies on the chemotherapy of experimental brain tumors: development of an experimental model | Q34234535 | ||
| Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma | Q34410560 | ||
| Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma | Q34509145 | ||
| Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. | Q34554842 | ||
| Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma | Q34641903 | ||
| 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. | Q34650300 | ||
| A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma | Q34979703 | ||
| Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment | Q35067532 | ||
| Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models. | Q52805669 | ||
| Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. | Q53399373 | ||
| Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancy. | Q55463985 | ||
| Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. | Q55466712 | ||
| Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. | Q55470277 | ||
| Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. | Q55472981 | ||
| Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme: what does it tell us about the models and about glioblastoma biology and therapy? | Q55475638 | ||
| Genome interpreter vies for place in clinical market | Q74203491 | ||
| PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
| NT113, a pan-ERBB inhibitor with high brain penetrance, inhibits the growth of glioblastoma xenografts with EGFR amplification | Q35190966 | ||
| Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies | Q35623965 | ||
| Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth | Q35695511 | ||
| Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System. | Q35799917 | ||
| Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug | Q36106198 | ||
| Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. | Q36385589 | ||
| A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells | Q36527913 | ||
| Establishment of human iPSC-based models for the study and targeting of glioma initiating cells | Q36611096 | ||
| Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model | Q36728282 | ||
| Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model | Q36982114 | ||
| Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis | Q37115208 | ||
| Development of a novel mouse glioma model using lentiviral vectors | Q37164106 | ||
| Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo | Q37207348 | ||
| Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis | Q37340787 | ||
| Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas | Q37658308 | ||
| The definition of primary and secondary glioblastoma | Q38064831 | ||
| Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. | Q38742530 | ||
| mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. | Q38794065 | ||
| ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. | Q38814097 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma | Q39161660 | ||
| Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR | Q40619097 | ||
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 | ||
| Growth of precultured human glioma specimens in nude rat brain | Q40940950 | ||
| Modeling Adult Gliomas Using RCAS/t-va Technology | Q41843698 | ||
| Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme | Q42124124 | ||
| Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice | Q42814832 | ||
| Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model | Q43170042 | ||
| Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy | Q45869340 | ||
| Genetic determinants of malignancy in a mouse model for oligodendroglioma | Q46129643 | ||
| Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach | Q46217247 | ||
| Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. | Q48088812 | ||
| Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice | Q48302625 | ||
| Expression of extracellular matrix components in a highly infiltrative in vivo glioma model | Q48429952 | ||
| High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model | Q48456290 | ||
| Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. | Q48476506 | ||
| Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation | Q48567039 | ||
| Astrocytomas in an inbred mouse strain | Q48830446 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | brain tumor | Q233309 |
| glioblastoma | Q282142 | ||
| animal disease model | Q64732998 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 423-432 | |
| P577 | publication date | 2017-10-20 | |
| 2017-12-01 | |||
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Current trends in mouse models of glioblastoma | |
| P478 | volume | 135 |
| Q58122179 | A Critical Overview of Targeted Therapies for Glioblastoma |
| Q64242985 | Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma |
| Q49256637 | Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma |
| Q91644172 | Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models |
| Q52579808 | Current Challenges and Opportunities in Treating Glioblastoma. |
| Q92500797 | Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer |
| Q64104892 | Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers |
| Q64057516 | Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma |
| Q92588700 | Long non-coding RNA HOTAIRM1 promotes proliferation and inhibits apoptosis of glioma cells by regulating the miR-873-5p/ZEB2 axis |
| Q90619539 | Magnetic resonance imaging-guided radiation therapy using animal models of glioblastoma |
| Q95936527 | Nanomedicine-based immunotherapy for central nervous system disorders |
| Q64100758 | Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma |
| Q64065735 | Visualization of spatiotemporal dynamics of human glioma stem cell invasion |
Search more.